Payments to Acquire Property, Plant, and Equipment of Lyell Immunopharma, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Lyell Immunopharma, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Lyell Immunopharma, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $246,000, a 720% increase year-over-year.
  • Lyell Immunopharma, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $780,000, a 68% increase from 2024.
  • Lyell Immunopharma, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $464,000, a 83% decline from 2023.
  • Lyell Immunopharma, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $2,686,000, a 89% decline from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Lyell Immunopharma, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $780,000 +$316,000 +68% 01 Jan 2025 31 Dec 2025 10-K 12 Mar 2026 2025 FY
2024 $464,000 -$2,222,000 -83% 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2023 $2,686,000 -$21,590,000 -89% 01 Jan 2023 31 Dec 2023 10-K 12 Mar 2026 2025 FY
2022 $24,276,000 -$41,228,000 -63% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025 2024 FY
2021 $65,504,000 +$14,023,000 +27% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $51,481,000 +$35,434,000 +221% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $16,047,000 01 Jan 2019 31 Dec 2019 10-K 29 Mar 2022 2021 FY

Lyell Immunopharma, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $246,000 +$216,000 +720% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $30,000 -$1,503,000 -98% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $1,533,000 -$8,200,000 -84% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q1 2022 $9,733,000 -$9,457,000 -49% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $19,190,000 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.